Induced Antileukemic Activity after Blast Modulation is Independent from Immune Checkpoint Marker Expression on Patients’ Blasts or T Cells. Archives of Clinical and Biomedical Research, v. 9, n. 6, p. 521–541, 18 Dec.2025.